ClinVar Miner

Submissions for variant NM_173477.5(USH1G):c.1373A>T (p.Asp458Val)

gnomAD frequency: 0.00001  dbSNP: rs397517925
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000041415 SCV000065110 likely pathogenic Rare genetic deafness 2011-10-03 criteria provided, single submitter clinical testing The Asp458Val variant in USH1G has been identified as a homozygous variant in tw o Turkish probands with moderate to severe and profound hearing loss and was als o detected in 1/498 Turkish control chromosomes (Kalay 2005). In addition, the v ariant was also homozygous in four affected relatives of these probands, and 18 unaffected relatives were either heterozygous for the variant or were wild-type. The affected individuals in these two families were not reported to have vestib ular dysfunction, and did not report visual problems; however funduscopy suggest ed mild retinitis pigmentosa. Electroretinograms were not performed in affected individuals (Kalay 2005). In summary, this variant is likely to be pathogenic, t hough additional studies are required to fully establish its clinical significan ce.
Labcorp Genetics (formerly Invitae), Labcorp RCV001382883 SCV001581838 pathogenic not provided 2022-01-06 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 458 of the USH1G protein (p.Asp458Val). This variant is present in population databases (rs397517925, gnomAD 0.002%). This missense change has been observed in individual(s) with atypical Usher syndrome (PMID: 16283141, 28944237). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 48127). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). Experimental studies have shown that this missense change affects USH1G function (PMID: 20142502). For these reasons, this variant has been classified as Pathogenic.
Center of Genomic medicine, Geneva, University Hospital of Geneva RCV001799509 SCV001739292 likely pathogenic Usher syndrome type 1G 2019-04-26 criteria provided, single submitter clinical testing This variant was identified in an homozygous state in a young female patient profound hearing loss. It was inherited from both parents (asymptomatic heterozygous carriers).
Laboratory of Prof. Karen Avraham, Tel Aviv University RCV001799509 SCV005073817 pathogenic Usher syndrome type 1G 2024-06-10 criteria provided, single submitter research Pathogenic by Deafness Variation Database based on PMID: 16283141

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.